MDMA Will Focus On FDA Performance, Device Tax Repeal In 2013

MDMA Will Focus On FDA Performance, Device Tax Repeal In 2013-thegratsheet: Priorities in 2013 will look a lot like last year's for the Medical Device Manufacturers Association, as the trade group maintains its focus on FDA implementation of the latest user fee agreement and repeal of the medical device excise tax. “We’re going to continue this year on our mission of promoting public health and improving patient care through the advocacy of innovative, research-driven medical device technology,” said Dan Moore, chairman of the MDMA board and CEO of neuromodulation technology firm Cyberonics